BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 11986217)

  • 1. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
    Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
    Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
    Paul BZ; Jin J; Kunapuli SP
    J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
    Lova P; Campus F; Lombardi R; Cattaneo M; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2004 Jun; 279(24):25299-306. PubMed ID: 15078882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt activation in platelets depends on Gi signaling pathways.
    Kim S; Jin J; Kunapuli SP
    J Biol Chem; 2004 Feb; 279(6):4186-95. PubMed ID: 14623889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-induced Akt activation--regulation and possible function.
    Reséndiz JC; Kroll MH; Lassila R
    J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
    Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
    J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
    Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
    Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP
    J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
    Shankar H; Murugappan S; Kim S; Jin J; Ding Z; Wickman K; Kunapuli SP
    Blood; 2004 Sep; 104(5):1335-43. PubMed ID: 15142872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
    Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
    Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
    Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR
    J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
    Chaudhary PK; Kim S
    J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.
    Srinivasan S; Mir F; Huang JS; Khasawneh FT; Lam SC; Le Breton GC
    J Biol Chem; 2009 Jun; 284(24):16108-16117. PubMed ID: 19346255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y
    Whitley MJ; Henke DM; Ghazi A; Nieman M; Stoller M; Simon LM; Chen E; Vesci J; Holinstat M; McKenzie SE; Shaw CA; Edelstein LC; Bray PF
    J Thromb Haemost; 2018 Dec; 16(12):2501-2514. PubMed ID: 30347494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of adenosine diphosphate in the course of thrombin signal transmission].
    Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
    Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
    Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
    Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.